** Shares of specialty chemicals company Cabot Corp CBT.N
decline 10.4% to $66.86
** Co says not seeing the anticipated pace of recovery in
China after a challenging March quarter in its Performance
Chemicals unit
** Says sales volumes in the Performance Chemicals unit for
April and May 2023 were 13% lower than the same months of 2022
** "In addition to the weakness in China, we continue to see
soft demand on a global basis across many of our key end
markets, including construction and consumer applications" - CEO
Sean Keohane
** CBT no longer expecting adjusted earnings per share for
fiscal 2023 to be in the range of $6.10 to $6.50
** CBT shares flat so far this year
(Reporting by Arunima Kumar)
((Arunima.Kumar@thomsonreuters.com; Twitter: https://twitter.com/Aru_Kumar94
;))